We have also previously shown that the protective counter-regulatory pathways, including the ACE-2/Ang-(1–7) pathway (8,11), and aminopeptidase-mediated conversion of ANG-II to Ang-III/Ang-IV (12) are dysregulated in AD. This evidence concerns the gene ACE2 and Alzheimer disease.